Illumina 8-K Signals Executive/Compensation Change on Jan 4, 2024

TL;DR

**Illumina filed an 8-K on Jan 4, 2024, indicating a significant executive or compensation change.**

AI Summary

Illumina, Inc. filed an 8-K on January 4, 2024, to report an event that occurred on the same date. This filing indicates a change in leadership or executive compensation, specifically under Item 5.02, which covers the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.' While the specific details of the change are not provided in this excerpt, investors should pay attention as changes in key personnel or their compensation can signal shifts in company strategy or financial health, potentially impacting stock performance.

Why It Matters

Changes in executive leadership or compensation can significantly influence a company's direction and financial stability, directly affecting investor confidence and stock valuation.

Risk Assessment

Risk Level: medium — The filing indicates a change in leadership or compensation, which can introduce uncertainty regarding future company performance and strategy.

Analyst Insight

A smart investor would monitor subsequent filings or company announcements for specific details regarding the executive or compensation changes mentioned in this 8-K, as these details will clarify the potential impact on Illumina's future performance.

Key Players & Entities

• Illumina, Inc. (company) — the registrant filing the 8-K
• January 4, 2024 (date) — date of earliest event reported and filing date
• 001-35406 (other) — Commission File Number for Illumina
• Delaware (other) — State of incorporation for Illumina
• 33-0804655 (other) — I.R.S. Employer Identification No. for Illumina
• 5200 Illumina Way, San Diego, CA 92122 (other) — Address of principal executive offices for Illumina
• 858-202-4500 (other) — Registrant’s telephone number
• ILMN (other) — Trading Symbol for Illumina Common Stock
• NASDAQ (other) — Exchange on which Illumina Common Stock is registered

FAQ

From the Filing

0000950157-24-000024.txt : 20240104 0000950157-24-000024.hdr.sgml : 20240104 20240104171145 ACCESSION NUMBER: 0000950157-24-000024 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240104 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 24513190 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 form8-k.htm CURRENT REPORT falseIllumina, Inc.0001110803CA00011108032023-08-312023-08-31 false 0001110803 0001110803 2024-01-04 2024-01-04 [    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2024 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware (State or other jurisdiction of incorporation)   33-0804655 (I.R.S. Employer Identification No.)   5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 ) 202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 par value   ILMN   NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 4, 2024, Illumina, Inc. (the “Company”) announced that Susan Tousi, Chief Commercial Officer, will be leaving the Company effective as of January 5, 2024, and that Bas Verhoef, Head of Region – Europe, will serve as Interim Chief Commercial Officer. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   ILLUMINA, INC.